CXCL11 and hepatocellular carcinoma: The metastatic and angiogenic properties of IL-17 have been studied in various experimental models, such as through the discovery that CAF-secreted CXCL11 upregulates the expression of circUBAP2 within HCC cells, which counteracts the inhibitory effect of miR-4756 on IFIT1 and IFIT3 [125].